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DO THE EFFECTS OF VITAMIN D 
SUPPLEMENTATION ON MUSCLE STRENGTH 
DIFFER ACCORDING TO AGE?
D VİTAMİNİN KULLANIMININ KAS KUVVETİNE 
ETKİSİ YAŞA GÖRE DEĞİŞİR Mİ?
Introduction: Vitamin D plays an important role in musculoskeletal health and its use 
improves muscle strength. However, the effect of vitamin D use on muscle strength in women 
of different ages is yet to be investigated. Therefore, in this study, we aimed to evaluate the 
effect of vitamin D use on muscle strength in women of different age groups and determine 
the differences of muscle strength gain between age groups.
Materials and Method: Sixty-three women with calcidiol levels<30 ng/mL were randomly 
assigned and stratified by their age group as follows: Group I (aged 40–49 years), Group II (aged 
50–59 years) and Group III (aged 60–69 years). Calcidiol levels, body mass index, fat free mass, 
percent fat, grip strength, arm curl, chair stand and isokinetic concentric flexor and extensor 
peak torque and power at 60°•s−1 and 180°•s−1 were assessed at baseline and six months after 
oral cholecalciferol supplementation.
Results: Vitamin D supplementation caused significant improvement in body mass index, 
arm curl, grip strength and knee flexor and extensor peak torque and power at 60°•s−1 and 
180°•s−1 in all groups (p<0.05). Knee flexor power at 60°•s−1 and extensor power at 180°•s−1 
were significantly higher in group I than in group III (p<0.025).
Conclusion: Muscle strength in response to vitamin D supplementation increased in all 
age groups, and isokinetic muscle power was the highest in the youngest age group studied.
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Giriş: D vitamininin muskuloskeletal sağlık için önemli olduğu ve D vitamin kullanımının 
kas kuvvetini arttırdığı bilinmektedir. Ancak, farklı yaşlardaki kadınlarda, D vitamin kullanımının 
kas kuvvetine etki farklılığını araştıran çalışma yoktur. Bu nedenle bu çalışmada, farklı yaş 
gruplarındaki kadınlarda D vitamin kullanımının kas kuvvetine etkisini değerlendirmek ve yaş 
grupları arasındaki kuvvet değişim farkını belirlemek amaçlanmıştır. 
Gereç ve Yöntem: Kalsidiol düzeyi <30ng/ml olan altmış üç kadın rasgele olarak yaş 
gruplarına göre sınıflandırıldı ve tabakalandı: Grup I (40-49 yaş arasında), Grup II (50-59 yaş 
arasında), ve Group III (60-69 yaş arasında). Kalsidiol düzeyi, beden kütle indeksi, yağsız kütle, 
yüzde yağ, kavrama kuvveti, kol bükme, otur kalk testleri ile 600.s-1 and 1800.s-1 hızlarda 
izokinetik konsantrik fleksör ve ekstensör zirve tork ve güç başlangıçta ve oral kolekalsifereol 
verildikten altı ay sonra değerlendirildi. 
Bulgular: D vitamin kullanımı tüm yaş gruplarında beden kütle indeksi, kol bükme, 
kavrama kuvveti, 600.s-1 and 1800.s-1 hızlarda diz fleksör ve ekstensör zirve tork ve güçte artışa 
neden oldu (p<0.05). Grup I’de, Grup III’e kıyasla 600.s-1 hızda fleksör güç ve 1800.s-1 hızda 
ekstensör güç daha büyüktü (p<0.025). 
Sonuç: D vitamin kullanımı sonucu tüm yaş gruplarında kas kuvveti arttı ve izokinetik kas 
gücü artışının genç yaş grubunda daha fazla olduğu belirlendi.
Anahtar sözcükler: Beden kompozisyonu, Kas kuvveti, Vitamin D, Kadın
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INTRODUCTION
Muscle strength declines with age, and its loss is 
prominent in people over 40 years of age (1). Vitamin 
D has a small but positive effect on muscle strength 
(2), and the improvement of muscle strength with 
vitamin D supplementation can only be achieved in 
persons with vitamin D deficiency (3). On performing 
meta-analysis, no significant effect of vitamin D 
supplementation was noted on grip strength in 
adults with 25(OH)D levels>10 ng/mL, but a large 
effect was noted on hip muscle strength in adults 
with 25(OH)D levels<10ng/mL (4). Most of the 
improvement in lower extremity functions occurred 
in 25(OH)D concentrations between 9 and 16 ng/
mL, while the change was not as noticeable in the 
range of 16–37.6 ng/mL in older adults (5). In adults 
aged 65–102 years, vitamin 25(OH)D levels<10 
ng/mL were significantly associated with lower 
extremity performances, whereas serum 25(OH)D 
levels<20 ng/mL were significantly associated with 
grip strength (5,6). To the best of our knowledge, 
there is no study comparing the effects of serum 
25(OH)D levels on muscle strength and that of 
vitamin D supplementation on muscle strength gain 
across different age groups of women.
Some studies suggest that vitamin D improves 
isometric (7-11) or isokinetic muscle strength 
(7,12,13), while other studies suggest that it has no 
effect on isometric (12,14-16) and isokinetic muscle 
strength (17). However, no study has yet investigated 
the differences in isometric or isokinetic strength 
gain on vitamin D supplementation in different 
age groups of women. Therefore, this study was 
designed to determine the effects of vitamin D 
supplementation on isometric and isokinetic muscle 
strength and to assess whether these effects differ 
according to the ages of women.
MATERIALS AND METHOD
Sixty-three sedentary women (aged 40–69 years) 
with 25(OH)D levels<30 ng/mL and without a 
history of vitamin D use within the last six months 
participated in the study and provided written 
informed consent. Exclusion criteria included the 
presence of any of the following comorbidities that 
may affect vitamin D levels or physical performance: 
renal and liver diseases, endocrine and neurologic 
diseases, a history of myocardial disease within the 
last six months, gastrointestinal malabsorption, the 
use of medicines which may affect muscles and the 
history of trauma/surgery of related muscles. The 
patients were stratified into the following three age 
groups: Group I (40–49 years of age), Group II (50–
59 years of age) and Group III (60–69 years of age). 
Vitamin D supplementation with 300.000 IU 
oral cholecalciferol was administered to patients 
according to their vitamin D status in March 2013: 
three doses at 10-day intervals in patients with 
vitamin D levels ≤ 10 ng/mL, two doses at 15-
day intervals in patients with vitamin D levels of 
11–20 ng/mL and a single dose in patients with 
vitamin D levels of 21–30 ng/mL. Oral calcium 
supplementation was administered to patients with 
insufficient calcium intake to achieve a total daily 
calcium intake of 1000 mg. This study was approved 
by the Institutional Ethics Committee (decision 
no;date.4/5; 2012).
All the following outcome measures were 
assessed at baseline and on the sixth month 
following vitamin D supplementation.
Serum 25(OH)D (calcidiol) assays (DiaSorin, 
Stillwater, MN, USA) were performed using direct 
competitive chemiluminescence immunoassay. 
LIAISON assay is linear up to 125 ng/mL, the limit 
of detection is 3.5 ng/mL and the coefficient of 
variation ranges between 4.8% and 11.1%. Blood 
samples were obtained after overnight fasting. 
Serum samples were separated via centrifugation at 
3000 rpm for 10 minutes, and serum portions were 
stored at −80°C and later used for analysing 25(OH)
D levels.
Height was measured using a tape measure 
with the participant in standing position. Body Mass 
Index (BMI), fat free mass (FFM) and percentage 
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body fat were measured using Tanita Body 
Composition Analyzer (TANİTA MC-180MA).
The handgrip strength of the dominant limb 
was measured using a baseline hydraulic hand 
dynamometer in which the dynamometer was used 
with participants in seated positions, their elbow by 
their side and flexed to right angles and their wrists 
in neutral positions. For the analyses, the maximum 
force from the three trials was used.
The chair stand test assessed lower body 
strength. The score was the total number of stands 
correctly executed within 30 seconds. The dominant 
side of the arm curl test assessed upper body 
strength. The score was the total number of hand 
weight curls through the full range of motion in 30 
seconds (18). Isokinetic concentric measurements of 
knee flexor/extensor muscles at 60°·s−1 and 180°·s−1 
were evaluated using ISOMED2000 (model code 
106-012, Hemau/Germany/2008). The test protocol 
included five maximal contractions at each speed 
with 1-minute intervals between each speed. The 
relative peak torque and power values were used 
in the analysis.
The study participants were assessed for any 
adverse reactions of vitamin D supplementation 
during and at the end of the study.
Statistical analysis
Data were analysed using the SPSS software 
(version 18.0). One-way ANOVA test was used for 
comparing baseline values and the post-hoc Tukey 
test was used. The level of significance was set at 
0.05. Multiple 3×2 (group×time) repeated measures 
ANOVA were performed for identifying significant 
changes over time. When significant differences 
were observed between groups at the start of the 
study, analysis of covariance was performed on 
the outcome variables at the end of the study. The 
covariate was the baseline value of each participant 
for the particular outcome variable being analysed. 
Post-hoc analyses were conducted using the 
Bonferroni test for examining time and group 
effects. The level of significance was set at 0.025; 
that is, 0.05 divided by 2. 
RESULTS
In the present study, we included 20 patients in the 
group I, 24 patients in the group II and 19 patients 
in the group III. One patient was excluded after 
stratification because of a haemorrhagic stroke. 
Vitamin D treatment was not associated with any 
clinically adverse reactions. Laboratory results 
revealed that serum 25(OH)D levels were <10ng/
mL in 95% of participants in groups I and III and in 
92% of participants in the group II. At baseline, no 
significant difference was noted in serum vitamin 
D levels among the groups (p>0.05) (Table 1).
Baseline BMI, FFM and percent fat 
measurements did not significantly differ among 
the study groups, and no significant differences 
were noted between groups I and II regarding 
isokinetic measurements (p>.05). Chair stand and 
grip strength test scores were higher in group I 
than in groups II and III and arm curl test scores 
were higher in the group I when compared with 
those in group the III and in group the II when 
compared with those in the group III (p<.05). No 
significant differences were noted between groups 
II and III for the chair stand and grip strength tests 
or between groups I and II for the arm curl test 
(p>.05). Furthermore, extension torque and power 
at 60°·s−1 and 180°·s−1 and flexion torque at 60°·s−1 
were higher in the group I than in the group III 
(p<.05). The flexion torque and power at 60°·s−1 
and extension torque at 60°·s−1 were higher in the 
group II than in the group III (p<.05) (Table 1).
According to the 25(OH)D blood 
concentrations at the end of the study, 70% and 
71% of women in groups I and II, respectively, 
reached levels >30ng/mL, whereas only 37% of the 
women in group III reached these levels. Repeated 
measures of ANOVA revealed a significant time 
effect for 25(OH)D levels (p<.025), while no group 
effect was noted (p>.025) (Table 1).
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There were no significant time effect for the FFM 
and percent fat values (p>.025) but did so for BMI 
(p<.025). No significant group effects were noted for 
BMI, FFM and percent fat values (p>.025) (Table 1).
There was no significant time effect for the chair 
stand test (p>.025), whereas significant time effects 
were noted for grip strength, arm curl, flexor and 
extensor torque and power at 60°·s−1 and 180°·s−1 for 
all groups (p<.025). The performance of flexor power 
at 60°·s−1 and that for extensor power at 180°·s−1 were 
higher in group I than in group III (p<.025) (Table 1).
DISCUSSION
The results in this study demonstrated that vitamin 
D supplementation improved BMI, arm curl, grip 
strength as well as flexor, extensor torque, and power 
at 60°·s−1 and 180°·s−1 in all age groups. The effect 
sizes for flexion power at 60°·s−1 and extension power 
at 180°·s−1 were greater in group 1 than in the group 3.
At baseline, 25(OH)D levels were <15 ng/mL 
(range 4–14 ng/mL) in all groups without any significant 
differences. Chair stand and grip strength were higher 
in group I than in groups II and III, while arm curl was 
lower in group III than in groups I and II. Flexor and 
extensor torque at 60°·s−1 were significantly lower in 
group III than in groups I and II. Extensor power at 
60°·s−1 and 180°·s−1 and extensor torque at 180°·s−1 
were significantly lower in group III than in group I, 
while flexion power at 60°·s−1 and 180°·s−1 and also 
flexion torque at 180°·s−1 were significantly lower in 
group III than in group II. These fındings suggested 
that muscle strength and power correlated with age 
rather than with vitamin D levels.
Grip strength was lower than normative values 
in all groups at baseline (19). Conflicting results have 
been reported regarding the relation between vitamin 
D and grip strength, with some studies proposing 
the presence of such a relation (6,7,11) while others 
proposing the lack of a relation (12). A study reported 
that women with serum vitamin D levels <30ng/mL 
had lower grip strength (11), while another study 
reported that grip strength was lower when serum 
vitamin D levels were <20ng/mL in both sexes (6). In 
addition, various cut-off levels were defined for serum 
vitamin 25(OH)D levels in studies investigating the 
relation between the physical performance of lower 
extremities. In some studies, physical performance 
was reportedly lower at vitamin 25(OH)D levels 
<10ng/mL (6), while other studies proposed different 
levels such as <32 ng/mL (20) and <30ng/mL (11,13). 
In a study on individuals older than 60 years of age 
(51 women, 75% physically active), lower extremity 
performances were suggested to be worse when 
serum 25(OH)D concentrations were between 9 
and 16ng/mL (5). In the present study, we could not 
determine whether group differences in muscle 
strength, muscle power and physical performances 
were associated with age or serum vitamin D levels 
because none of the participants had normal vitamin 
D levels.
Although it has been reported that there was 
no significant effect of vitamin D on muscle power 
(2,11,14), Bischoof et al.(20) stated that there was 
a significant, positive correlation between muscle 
power and 25(OH)D only in male participants 
between 65 and 95 years of age. In another study, 
vitamin D was positively associated with isometric 
flexion and extension average torque at the knee 
and isokinetic flexion strength at 60°·s−1 and 180°·s−1; 
there was no correlation between vitamin D and knee 
isokinetic extension strength at 60°·s–1 and 180°·s−1 
(12). Previous studies have suggested that vitamin 
D affected isometric muscle strength (7-11) and 
isokinetic muscle strength (7,12,13), but other reports 
have proposed no effect (12,14-17). In this study, 
improvement was observed in the knee flexor as well 
as extensor torque and power at 60°·s−1 and 180°·s−1 
in all assessed age groups, and the between-group 
effect sizes for flexion power at 60°·s−1 and extension 
power at 180°·s−1 after vitamin D supplementation 
suggested that vitamin D was more effective for 
muscle power in younger age groups than in older 
ones. This outcome suggested that the effect of 
vitamin D supplementation depends on age and also 
on increased 25(OH)D levels because 25(OH)D levels 
were >30 ng/mL in 70% of participants in the group I 
and in 37% of participants in group III. Serum 25(OH)
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D level increment was 481% in group I, 404% in group 
II and 360% in group III. Grip strength increased from 
15% at baseline to 50% in group I, from 13% to 35% in 
group II and from 11% to 21% in group III. The increase 
in grip strength was consistent with the increase in 
serum vitamin D levels. It has been demonstrated 
that the greatest improvement of muscle strength 
occurred from very low concentrations of serum 
25(OH)D up to 16–20 ng/mL (5).
Even though vitamin D supplementation 
resulted in increased grip strength and isokinetic 
strength in our study, it had no effect on chair stand 
test performance. However, McCarthy et al.(21) 
stated that isokinetic knee extensor strength was an 
important but moderate predictor of chair stand test 
performance and additional independent variables 
such as leg power, leg endurance, posture, and 
psychological variables may have contributed to the 
variance in chair stand test performance.
Obesity is a major risk factor for vitamin D 
deficiency because of body fat absorption of vitamin 
D (11,22). BMI and higher body fat percentage are 
significantly associated with lower serum 25(OH)
D levels, especially in older persons, and there is a 
relation between vitamin D levels and adipose tissue 
(23). On the basis of this evidence, obese individuals 
are expected to require higher doses of vitamin 
D supplementation (22). The smaller increment of 
serum 25(OH)D levels in the group III depended 
on the percentage of obese participants in this age 
group. BMI was >30 kg/m2 in 54% of the group I, 60% 
of the group II and 79% of the group III in this study.
Although high doses of vitamin D were used 
in this study, there were no adverse reactions. In a 
previous review, it was suggested that doses <300.000 
IU do not provide an adequate amount of vitamin D 
for restoring vitamin D status in most populations, 
and the increases in 25(OH)D concentration safely 
occur in a majority of individuals (24). Moreover, this 
review highlighted previous works wherein there were 
no adverse events when participants received up to 
500.000 IU of vitamin D (24).
One of the limitations of the present study was its 
small sample size. In addition, there was a significant 
difference in muscle strength, especially for isokinetic 
muscle strength, between groups at baseline. 
Furthermore, the lack of a control group with different 
serum vitamin D levels is another study limitation. 
In addition, we did not have specific information 
regarding sunlight exposure. Lastly, we were unable 
to evaluate the response of muscle strength of 
different body regions to vitamin D supplementation. 
Randomised, controlled studies using a large sample 
of participants with different serum 25(OH)D levels are 
required for defining optimal treatment modalities, 
including the dose and mode of administration and 
duration. Future research may also identify factors 
such as age, sex, physical activity level, the number of 
concomitant medications and endogenous gonadal 
hormone levels that affect responses to vitamin D 
supplementation.
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